المؤلفون: Miyajima K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Uchida N; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Suzuki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei University Kashiwa Hospital, Kashiwa, Chiba., Imai Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aikawa K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei University Kashiwa Hospital, Kashiwa, Chiba., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Honda M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Koike Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miki J; Department of Urology, Jikei University Kashiwa Hospital, Kashiwa, Chiba., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Shimomura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yuen S; Department of Surgery, Division of Urology, Prince of Wales Hospital, Shatin, Hong Kong., Yamada Y; Department of Urology, University of Tokyo, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: furabe0809@gmail.com., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Apr; Vol. 22 (2), pp. 149-156.e1. Date of Electronic Publication: 2023 Oct 25.

نوع المنشور: Meta-Analysis; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/adverse effects , Carcinoma, Intraductal, Noninfiltrating*/etiology , Prostatic Neoplasms*/pathology, Male ; Humans ; Prostate/pathology ; Retrospective Studies ; Clinical Relevance

المؤلفون: Nakazono M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Imai Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Honda M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Koike Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Shimomura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2023 Dec; Vol. 30 (12), pp. 1147-1154. Date of Electronic Publication: 2023 Aug 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/drug therapy , Brachytherapy*/adverse effects, Male ; Humans ; Prostate-Specific Antigen ; Androgen Antagonists/therapeutic use ; Risk ; Radiotherapy Dosage

المؤلفون: Miyajima K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Suzuki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. furabe0809@gmail.com., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Imai Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yasue K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Koike Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miki J; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yuen S; Division of Urology, Department of Surgery, Queen Mary Hospital, University of Hong Kong, Pok Fu Lam, China., Sasaki T; Department of Nephrology and Hypertension, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2023 Sep; Vol. 28 (9), pp. 1200-1206. Date of Electronic Publication: 2023 Jul 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/adverse effects , Prostatic Neoplasms*/pathology , Urinary Bladder Neoplasms*/radiotherapy , Urinary Bladder Neoplasms*/etiology, Male ; Humans ; Retrospective Studies ; Urinary Bladder ; Prostatectomy

المؤلفون: Kadena S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. furabe0809@gmail.com., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Suzuki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Imai Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Honda M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Koike Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Shimomura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2023 Aug; Vol. 28 (8), pp. 1092-1100. Date of Electronic Publication: 2023 May 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/adverse effects , Prostatic Neoplasms*/radiotherapy, Male ; Humans ; Prognosis ; Retrospective Studies ; Androgen Antagonists/therapeutic use ; Radiotherapy Dosage

المؤلفون: Suzuki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; furabe0809@gmail.com., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miyajima K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Imai YU; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Honda M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Koike Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: Anticancer research [Anticancer Res] 2023 Jul; Vol. 43 (7), pp. 3135-3143.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/methods , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/pathology, Male ; Humans ; Androgen Antagonists/therapeutic use ; Androgens ; Retrospective Studies ; Prospective Studies ; Prostate/pathology ; Radiotherapy Dosage

المؤلفون: Enei Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; kentamiki@jikei.ac.jp., Suzuki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Furuta A; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Sasaki T; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: Anticancer research [Anticancer Res] 2023 Jul; Vol. 43 (7), pp. 3159-3166.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/adverse effects , Prostatic Neoplasms*/drug therapy, Male ; Humans ; Retrospective Studies ; Androgen Antagonists/therapeutic use ; Follow-Up Studies ; Radiotherapy Dosage ; Radiation Dosage

المؤلفون: Imai Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. furabe0809@gmail.com., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Nakazono M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Honda M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2023 May; Vol. 28 (5), pp. 698-706. Date of Electronic Publication: 2023 Feb 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/adverse effects , Prostatic Neoplasms*/radiotherapy, Male ; Humans ; Retrospective Studies ; Radiotherapy Dosage ; Prognosis

المؤلفون: Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Sasaki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Matsukawa A; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aikawa K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsusumi Y; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Morikawa M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Minato K; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Egawa S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: The Prostate [Prostate] 2023 Feb; Vol. 83 (2), pp. 135-141. Date of Electronic Publication: 2022 Sep 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/adverse effects , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/surgery , Prostatic Neoplasms*/pathology, Male ; Humans ; Prostate-Specific Antigen ; Propensity Score ; Prostatectomy ; Retrospective Studies

المؤلفون: Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. furabe0809@gmail.com., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Sasaki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Egawa S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2022 Feb; Vol. 27 (2), pp. 411-417. Date of Electronic Publication: 2021 Oct 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy* , Prostatic Neoplasms*/radiotherapy, Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Prognosis ; Prostate-Specific Antigen ; Radiotherapy Dosage

المؤلفون: Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. furabe0809@gmail.com., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Sasaki H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tashiro K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yasue K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Aoki M; Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan., Sato S; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Takahashi H; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan., Miki K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Egawa S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2022 Jan; Vol. 27 (1), pp. 184-193. Date of Electronic Publication: 2021 Oct 02.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy* , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/radiotherapy, Combined Modality Therapy ; Humans ; Male ; Neoadjuvant Therapy ; Prospective Studies ; Prostate-Specific Antigen ; Radiotherapy Dosage